Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

272 results about "Phosphatidylserines" patented technology

Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a SERINE moiety.

Method for preparing phosphatidylserine through interfacial enzyme catalysis

The invention belongs to the field of enzymatic preparation of structural phospholipids, and particularly relates to a method for preparing phosphatidylserine through interfacial enzyme catalysis. A series of high-activity immobilized phospholipase are prepared by innovatively adopting bifunctional group modified hollow mesoporous silica microspheres as a carrier and adsorbing immobilized phospholipase D. The catalyst has the functions of a catalyst and an emulsifier, and a Pickering emulsion interfacial enzyme catalysis system can be efficiently constructed. In the system, the phosphatidylcholine and the serine are efficiently converted into the phosphatidylserine through a phosphatidyl transfer reaction, the conversion rate of the phosphatidylserine within 20 minutes can reach 85%-95%, and the catalytic efficiency reaches up to 372 mmol / (g.h). In addition, after the catalyst is recycled for 10 times, the conversion rate is still kept at 70.9%, and the catalyst shows excellent stability and reusability. The method has the remarkable advantages of being mild in reaction condition, high in catalytic efficiency, capable of being repeatedly used and the like, and a new technical approach is provided for industrial production of phosphatidylserine.
Owner:OIL CROPS RES INST CHINESE ACAD OF AGRI SCI

Lipid nanoparticles for delivery of nucleic acids and methods of use thereof

The present disclosure provides for improved compositions of ionizable lipid nanoparticles for the delivery of therapeutic nucleic acids to cells. Anionic phospholipids, including phosphatidyl serine and phosphatidylglycerol are included in the lipid nanoparticles to increase the transfection efficiency in human dendritic cells. The further incorporation of mono-unsaturated alkyl chain analogs in dimethylaminopropyl-di oxolane or heterocyclic ketal ionizable lipids in the formulation demonstrated high levels of transfection in human dendritic cells, compared to other ionizable lipids in the same family, and demonstrated good stability to oxidative damage. Finally, the use of an ammonium salt of phosphatidylserine allows for the efficient production of PS-targeted LNPs.
Owner:AKAGERA MEDICINES INC

Method for preparing high-purity phosphatidylserine by batch enzyme catalysis method based on dynamic choline removal

The invention provides a method for preparing high-purity phosphatidylserine by a batch enzyme catalysis method based on dynamic choline removal, and belongs to the technical field of enzymatic reaction. According to the method disclosed by the invention, in a reaction system for preparing phosphatidylserine, a byproduct choline is selectively adsorbed by adopting resin. Choline in a reaction system is removed in real time through the integrated adsorption separation module, the enzyme inhibition problem is solved, and meanwhile, the PC conversion rate is larger than or equal to 98% and the PS purity is larger than or equal to 96% in combination with the immobilized enzyme circulation technology; the enzyme can be reused for more than or equal to 20 times (activity retention is more than or equal to 90%); and the choline residual concentration is less than or equal to 0.5 mM (an inhibition threshold value or less).
Owner:SICHUAN KANGLIAN BIOTECHNOLOGY CO LTD

Radioimmunoconjugates targeting phosphatidylserine for use in the treatment of cancer

Methods for treating cancers and precancerous conditions by administering an effective amount of a radiolabeled agent that targets cell surface phosphatidylserine, alone or in combination with other therapies, are provided. The radiolabeled phosphatidylserine targeting agent delivers radiation to cells that externally present phosphatidylserine, such as tumor cells, depleting those cells and neighboring malignant cells to effect overall tumor reduction. Radiation delivered by the radiolabeled phosphatidylserine targeting agent itself increases the cell surface expression of phosphatidylserine, leading to a feed-forward mechanism that drives further accumulation of the phosphatidylserine targeting agent at target lesions to enhance its therapeutic effect.
Owner:ACTINIUM PHARMACEUTICALS INC

Yak milk powder helpful for promoting bone growth and development

The invention relates to the technical field of yak milk powder, and discloses yak milk powder helpful for promoting bone growth and development. Comprising the following specific raw materials: basic raw materials: raw yak milk, dried skim milk, cattle spleen peptide powder, colostrum powder, hydrolyzed yolk powder, phosphatidylserine, N-acetylneuraminic acid, colostrum basic protein, lactoferrin, docosahexaenoic acid, arachidonic acid, xanthophyll and choline; the polypeptide combination comprises Chinese yam peptide powder, poria cocos peptide powder, hawthorn peptide powder, endothelium corneum gigeriae galli peptide powder, walnut peptide and yak bone peptide. Through polypeptide combination of colostrum basic protein and composite mineral supplement, digestion and absorption of children to yak milk powder are promoted, various mineral substances needed by the body are supplemented, immunity is enhanced, bone growth is promoted, multivitamins needed by the body are supplemented by multivitamins, growth and development are promoted, bone growth is indirectly supported, and the yak milk powder has the effects of improving the immunity and improving the immunity. The requirements of children on the key nutrients in the bone growth and development stage are met.
Owner:周建宜

Antibody or antigen binding fragment thereof and application thereof

The invention provides a target antibody or an antigen binding fragment thereof and application thereof, and belongs to the field of antibodies. Wherein the antibody or the antigen binding fragment thereof comprises a heavy chain complementarity determining region HCDR, and the HCDR comprises at least one selected from SEQ ID NO: 1-18 or an amino acid sequence having at least 80% homology with the HCDR. The antibody or the antigen-binding fragment thereof can bind to TIM-1 protein with high specificity and affinity, increase the blocking of TIM-1 activity so as to enable the TIM-1 to interact with ligands such as phosphatidylserine, TIM-4 and galectin-9, and enhance immune response.
Owner:UNIV OF SCI & TECH OF CHINA

Lipid nanoparticles for delivery of nucleic acids and methods of use thereof

The present disclosure provides for improved compositions of ionizable lipid nanoparticles for the delivery of therapeutic nucleic acids to cells. Anionic phospholipids, including phosphatidylserine and phosphatidylglycerol are included in the lipid nanoparticles to increase the transfection efficiency in human dendritic cells. The further incorporation of mono-unsaturated alkyl chain analogs in dimethylaminopropyl-dioxolane or heterocyclic ketal ionizable lipids in the formulation demonstrated high levels of transfection in human dendritic cells, compared to other ionizable lipids in the same family, and demonstrated good stability to oxidative damage. Finally, the use of an ammonium salt of phosphatidylserine allows for the efficient production of PS-targeted LNPs.
Owner:AKAGERA MEDICINES INC

Phosphatidylserine nervonic acid gel candy capable of improving concentration and preparation method of phosphatidylserine nervonic acid gel candy

The invention relates to the technical field of biology, and particularly discloses phosphatidylserine nervonic acid gel candies capable of improving concentration and a preparation method of the phosphatidylserine nervonic acid gel candies. The invention relates to a phosphatidylserine nervonic acid gel candy for improving concentration. Comprising the following raw materials in parts by weight: 50 to 200 parts of phosphatidylserine, 10 to 30 parts of cis-15-tetracosenoic acid, 1 to 10 parts of a balm extract, 1 to 10 parts of a salvia officinalis extract, 1 to 10 parts of N-acetylneuraminic acid, 1 to 10 parts of tea theanine, 100 to 400 parts of medium chain triglyceride, 5 to 40 parts of beeswax, 5 to 40 parts of phospholipid and the balance of purified water. The composition can be used for improving concentration and has the advantages of being good in stability, good in taste and high in acceptability.
Owner:DR DODO HEALTH TECH (HANGZHOU) CO LTD

Antarctic krill oligopeptide nutritional composition for promoting neural development and application thereof

The invention discloses an euphausia superba oligopeptide nutritional composition for promoting neural development and application thereof, and belongs to the technical field of functional foods.The nutritional composition is prepared from, by weight, 0.01-10 parts of docosahexaenoic acid, 0.01-20 parts of arachidonic acid, 0.01-10 parts of phosphatidylserine and 0.01-80 parts of euphausia superba oligopeptide. The antarctic krill oligopeptide is obtained by treating antarctic krill, antarctic krill powder or degreased antarctic krill powder by utilizing an enzymolysis method, and the content of a peptide fragment with the molecular weight of less than 1000Da in the antarctic krill oligopeptide is more than 90%. The raw materials of the composition are easy to obtain, the safety is high, and the composition can be used for preparing products with the function of promoting neurodevelopment and can be taken as common food, health care products or medicines for a long time.
Owner:HANGZHOU QIANDAOHU KANGNUOBANG HEALTH PROD CO LTD

Preparation method of composite spray for improving hemostatic capacity of wound part

The invention discloses a preparation method of a composite spray for improving the hemostatic ability of a wound part, the composite spray comprises a liquid A and a liquid B. The liquid B is a sodium alginate aqueous solution, a preparation method of the solution A comprises the following steps: 1, dissolving a lipopeptide conjugate, cholesterol, distearoyl phosphatidylcholine, distearoyl phosphatidylserine and dimethyl sulfoxide in a chloroform-methanol mixed solution to obtain a mixed system; 2, preparing the mixed system into a precursor solution by utilizing a film hydration method; 3, adding calcium chloride into the precursor solution, and reacting in a dark place to obtain a solution A; a precursor solution is designed according to the function of natural platelets, the function of the precursor solution is equivalent to that of nano platelets, the precursor solution is matched with sodium alginate, adverse effects on a blood coagulation system caused by fibrin degradation, platelet activation capability reduction and the like of a wound part due to blood loss can be relieved in a targeted manner, and the preparation has the advantages of rapid hemostasis, good biological activity, no toxic or side effects and the like. And the wound healing is rapid.
Owner:NORTHWEST UNIV

Modified pseudo-ginseng exosome as well as intestinal conditioning gel composition and application thereof

The invention relates to the technical field of functional food and biological medicine, in particular to a modified pseudo-ginseng exosome and an intestinal conditioning gel composition and application thereof. According to the gel beverage, an exosome derived from panax notoginseng callus cultured in a laboratory is used as a core active component, is modified through phosphatidylserine-aminated pectin-genipin and is embedded into a hydrogel matrix composed of carboxymethyl chitosan and sodium alginate, so that the exosome is protected from being degraded in the stomach, and the activity of the exosome in the stomach is improved. The exosome can be effectively released under the intestinal pH and flora environment, so that the targeted delivery of the intestinal tract is realized, and the preparation method is suitable for improving the intestinal inflammation and maintaining the intestinal health. The invention can effectively solve the technical problems of uncontrollable raw material quality and safety, low oral delivery stability and active ingredient availability and poor medication compliance of the existing plant exosome.
Owner:JIANGSU JICUI FUNCTIONAL MATERIALS RES INST CO LTD

Application of phospholipase D mutant in biosynthesis of phosphatidylserine

The invention provides a phospholipase D mutant and application thereof, compared with an amino acid sequence SEQ ID NO.2, four sites of Y6570, D6595, R6661 and D6669 in the amino acid sequence SEQ ID NO.2 are respectively subjected to single mutation, pairwise combined mutation, three combined mutation or one of four combined mutation; the novel phospholipase D mutant industrial enzyme is used for synthesizing and preparing L-phosphatidylserine. The phospholipase D mutant enzyme constructed by the invention has the characteristics of low enzyme cost, short conversion time, simple process operation and the like, and has a wide prospect of large-scale industrial application.
Owner:GUANGDONG SHENGSHI HERBAL BIOTECHNOLOGY CO LTD

Lipid composition for preparing extracellular vesicles

The invention discloses a lipid composition for preparing extracellular vesicles, which is prepared from the following lipid substances in percentage by mass: 2 to 18 percent of phosphatidylcholine, 2 to 14 percent of phosphatidylethanolamine, 7 to 27 percent of sphingomyelin, 0.5 to 7 percent of ceramide, 1.5 to 2.5 percent of phosphatidylinositol, 30 to 70 percent of cholesterol and 5 to 8 percent of phosphatidylserine, the fatty acid carbon number of the lipid substance satisfies the following conditions: the fatty acid carbon number of phosphatidylcholine is 16-20, the fatty acid carbon number of phosphatidyl ethanolamine is 16-18, the fatty acid carbon number of sphingomyelin is 16-24, the fatty acid carbon number of ceramide is 16-24, the fatty acid carbon number of phosphatidylinositol is 16-20, the fatty acid carbon number of phosphatidylserine is 18-24, and the molar ratio of cholesterol to sphingomyelin is 4-7. The extracellular vesicles are prepared from the lipid composition and used for biomarkers or drug carriers, and efficient oral drug delivery is achieved.
Owner:JIANGNAN UNIV

Functionalized drug-loaded exosomes based on milk exosomes and preparation method and application thereof

The present invention belongs to the field of biotechnology and pharmaceutical engineering technology, and discloses a functionalized drug-loaded exosome based on milk exosomes, a preparation method thereof, and an application thereof. The functionalized drug-loaded exosomes include a carrier and a water-insoluble drug, and the water-insoluble drug is loaded inside the carrier; wherein the surface of the carrier is loaded with milk exosomes with functionalized molecules, and the functionalized molecule is any one of phosphatidylserine, a molecule capable of macrophage targeting, and a molecule or polymer that enhances the targeting and stability of milk exosomes; the water-insoluble drug is any one of an antibacterial drug, an antitumor drug, and a gene drug. The functionalized drug-loaded exosomes in the present invention can improve the gastrointestinal stability of oral administration and enhance the efficacy against bacterial pathogens; expand the application scope of milk exosomes in the fields of anti-intestinal bacterial infection and food preservation, and the exosome content in milk is very rich, which is convenient for large-scale preparation and has important application value.
Owner:ANHUI AGRICULTURAL UNIVERSITY +1

Liposomes for inhibiting biofilm formation

The present invention relates to a composition comprising, preferably consisting of, (i) a single empty liposome, wherein said single empty liposome is selected from (a) an empty liposome comprising cholesterol, wherein the amount of cholesterol is at least 30% (weight per weight), wherein preferably said empty liposome comprising, further preferably consisting of, cholesterol and sphingomyelin; or (b) an empty liposome consisting of sphingomyelin; or (ii) a mixture of empty liposomes; wherein said mixture of empty liposomes comprises, preferably consists of, at least one empty liposome selected from (a) an empty liposome comprising cholesterol, wherein the amount of cholesterol is at least 30% (weight per weight), wherein preferably said empty liposome comprising, further preferably consisting of, cholesterol and sphingomyelin; (b) an empty liposome consisting of sphingomyelin; and (c) an empty liposome comprising, preferably consisting of, phosphatidylcholine and sphingomyelin; and at least one empty liposome independently of each other selected from an empty liposome comprising, preferably consisting of, lipids or phospholipids selected from cholesterol, sphingomyelins, ceramides, phosphatidylcholines, phosphatidylethanolamines, phosphatidylserines, diacylglycerols, and phosphatidic acids containing one or two or more saturated or unsaturated fatty acids longer than 4 carbon atoms and up to 28 carbon atoms; for use in a method for preventing or reducing biofilm formation or for eradicating or reducing existing biofilm.
Owner:COMBIOXIN SA

Liposomal compositions and methods of use thereof for improved stability, bioavailability & sustained release

The embodiments disclosed herein relate to a liposomal composition for sustained release of an active ingredient. In various implementations, the liposomal composition may have a first liposomal core of Phosphatidylcholine (PC), phosphatidylethanolamine (PE), or phosphatidylserine (PS) and the active ingredient dispersed within the first liposomal core. A second core may surround the first liposomal core, with the second core optionally containing one or more polypeptide and a polysaccharide.
Owner:SPECNOVA LLC

Uses of engineered yeast strains and lipid compositions thereof

PCT designated stageWO2025212524A1Organic active ingredientsDigestive systemMonoglycerideCellular Aging
Provided herein are methods and materials for using organisms (e.g., engineered yeast strain-derived) to generate lipid compositions which can modulate cellular aging, extend lifespan, and / or modulate gut homeostasis in a subject. The lipid compositions contain at least twelve of the lipids selected from a phosphatidylethanolamine (PE); a lysophosphatidylethanolamine (LPE); a diacylglycerol (DG); a monoglyceride (MG); an acyl carnitine (AcCa); a phosphatidic acid (PA); a phosphatidylglycerol (PG); a lysophosphatidylcholine (LPC); a triacylglycerol (TG); a cholesterol ester (ChE); a wax ester (WE); a phosphatidylserine (PS); a phosphatidylcholine (PC); a phosphatidylinositol (PI); a ceramide (Cer); and a lysophosphatidylserine (LPS).
Owner:RGT UNIV OF CALIFORNIA

Composition as well as preparation method and application thereof in protecting brain health

PendingCN121102248AOrganic active ingredientsNervous disorderNutritionBrain tissue injury
The invention belongs to the technical field of nutritional compositions, and particularly relates to a composition, a preparation method thereof and application of the composition in protecting brain health. The composition provided by the invention is prepared from docosahexaenoic acid, 3-sialic acid lactose and phosphatidylserine. The composition is clear in sleep improvement effect, can effectively solve the problem of sleep maintenance caused by sleep deprivation, has the effects of protecting neural functions, improving memory and relieving anxiety from multiple dimensions, and can repair brain tissue damage and protect brain health. Based on the composition, products for assisting in improving memory, preventing and treating insomnia and anxiety, regulating neurodevelopmental disorders, protecting brain health and improving concentration can be developed, the health requirements of different people are comprehensively met, and the application value is high.
Owner:BIOSTIME GUANGZHOU HEALTH PROD +1

Children growth milk powder containing medicinal and edible components and capable of promoting height growth

The invention discloses children growth milk powder containing medicinal and edible components and capable of promoting height growth. The milk powder consists of the following raw materials: raw milk, skimmed milk powder, isomaltooligosacharide, demineralized whey powder, vegetable oil, milk mineral salt, medicinal and edible composite plant powder, arachidonic acid, docosahexaenoic acid, colostrum basic protein, hydrolyzed yolk powder, phosphatidylserine, enzymolysis bone meal, N-acetylneuraminic acid, probiotic powder, lactoferrin, vitamins, minerals and inositol. , choline, taurine and xanthophyll. The invention belongs to the technical field of dairy products, and particularly provides children growth milk powder containing medicinal and edible components and capable of promoting children's brain development, bone growth, digestion, absorption and utilization and improving children's immunity.
Owner:HUNAN NANSHAN HEALTH IND CO LTD

Artificial blood vessel and preparation method thereof

The invention discloses an artificial blood vessel and a preparation method thereof, and relates to the technical field of artificial materials. The artificial blood vessel comprises a polymer spinning blood vessel base; the polymer coating with positive charges is attached to the surface of the polymer spinning blood vessel substrate; and the erythrocyte membrane vesicles of the eversion phosphatidylserine are attached to the surface of the positively charged polymer coating through electrostatic adsorption. The artificial blood vessel provided by the invention can inhibit blood vessel restenosis by virtue of the immune regulation and control capability of phosphatidylserine, and finally the long-term patency rate of the artificial blood vessel is improved.
Owner:HUAZHONG UNIV OF SCI & TECH

Nervonic acid nutritional composition for relieving sleep disorder and application of nervonic acid nutritional composition

The invention relates to the technical field of health food, in particular to a nervonic acid nutrient composition for relieving sleep disorder and application of the nervonic acid nutrient composition for relieving sleep disorder. The active components comprise natural vegetable oil such as acer truncatum seed oil purified nervonic acid, linseed oil and the like and gamma-aminobutyric acid extracted by fermentation; the synergistic component is prepared from soybean enzymolysis phosphatidylserine, saccharomycetes fermentation coenzyme Q10 and plant source B vitamins; the slow-release carrier adopts pectin-Arabic gum composite gel and plant starch to form a natural cross-linked structure, and long-acting release for 8-12 hours is realized through physical cross-linking. Green technologies such as ultrasonic dispersion and low-temperature drying are adopted in the preparation process, and chemical synthesis steps are avoided; the composition can improve the difficulty in falling asleep and improve the sleep quality, the activity retention rate is greater than or equal to 85% after the composition is stored at 45 DEG C for 6 months, and the composition is suitable for preparing capsules, gel candies and other health-care foods and has no dependence after being taken for a long time.
Owner:NAOYIKANG (HEBEI PROVINCE) BIOTECHNOLOGY CO LTD

Milk powder for promoting growth and development of children and preparation method thereof

The invention belongs to the technical field of milk powder formulas, and particularly relates to milk powder for promoting growth and development of children and a preparation method thereof. Comprising the following components: raw milk, whole milk powder, dried skim milk, lactose, isomaltooligosacharide, fructo-oligosaccharide, galactooligosaccharide, colostrum basic protein, whey protein powder, cattle spleen peptide powder, comprehensive fruit powder, hydrolyzed yolk powder, phosphatidylserine, xanthophyll, compound vitamins, compound minerals, choline chloride, L-carnitine, calcium carbonate, milk mineral salt and lactoferrin. The composition is prepared from docosahexaenoic acid grease, plant lactobacillus YBT5 and plant lactobacillus SG5; in the preparation method of the milk powder, a dry-wet mixing method is adopted to obtain the milk powder. According to the formula, reasonable nutrients are selected, a comprehensive and balanced proportion is adopted, nutrition of children can be balanced, growth and development of the children can be promoted, and the milk powder is simple in preparation method, convenient to operate and suitable for large-scale production.
Owner:NUXTRILE (GUANGZHOU) NUTRITION CO LTD

Plant-derived apoptosis-imitating extracellular vesicle as well as preparation method and application thereof

The invention belongs to the technical field of nano biology, and discloses a plant-derived apoptosis-imitating extracellular vesicle as well as a preparation method and application of the plant-derived apoptosis-imitating extracellular vesicle. The preparation method comprises the following steps: extracting a plant source outer vesicle from a plant tissue, and co-fusing the plant source outer vesicle with a phosphatidylserine (PS) solution containing an apoptosis signal to obtain the plant source apoptosis-imitating extracellular vesicle. The plant-derived apoptotic extracellular vesicles disclosed by the invention are derived from natural plants, and compared with apoptotic cell vesicles derived from mammalian cells, the plant-derived apoptotic extracellular vesicles have good biocompatibility and are not easy to cause immunological rejection of organisms; compared with a natural plant-derived extracellular vesicle, the plant-derived apoptotic extracellular vesicle modified by phosphatidylserine (PS) has the advantages that the macrophage targeting property, the macrophage inflammatory reaction inhibition effect and the RA improvement effect of the plant-derived apoptotic extracellular vesicle are remarkably improved.
Owner:SHAOGUAN COLLEGE

A composition containing bird's nest acid, phospholipids and polyunsaturated fatty acids and preparation method thereof

The present invention provides a kind of composition containing bird's nest acid, phospholipid and polyunsaturated fatty acid and preparation method thereof, composition, when not adding any additives, bird's nest acid is dispersed in DHA grease in functional ingredients, while solving the problem that DHA is easily oxidized, promotes brain development, regulates immunity, promotes the absorption and utilization of minerals in the intestine and the effects of beauty and skin care. Phospholipids can prevent the sedimentation of bird's nest acid in ω 3 polyunsaturated fatty acid grease, and are phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol or phosphatidylserine. Not only can the sedimentation of bird's nest acid be prevented, but also the growth of nerve cells can be supported, thereby improving the absorption rate of DHA in the brain. Especially PS, itself can not only nourish the brain, enhance brain function, but also relieve mental stress and improve cognition, and is called "brain nutrient".
Owner:NANJING AURORA BOREALIS BIOTECHNOLOGY CO LTD

Phospholipase D mutant Lip-Gri / NQ, plasmid, recombinant bacterium and application of phospholipase D mutant Lip-Gri / NQ

The invention relates to a phospholipase D mutant Lip-Gri / NQ, a plasmid, a recombinant bacterium and application of the phospholipase D mutant Lip-Gri / NQ and belongs to the field of enzyme engineering, the amino acid sequence of the phospholipase D mutant is shown as SEQ ID NO: 1, and the nucleotide sequence of a gene for coding the phospholipase D mutant Lip-Gri / NQ is shown as SEQ ID NO: 2. The invention also provides a recombinant plasmid and an engineering bacterium containing the gene of the recombinant plasmid phospholipase D mutant Lip-Gri / NQ, and application of the phospholipase D mutant Lip-Gri / NQ in catalyzing phospholipids to generate specific-configuration functional lipids including phosphatidylserine. According to the phospholipase D Lip-Gri disclosed by the invention, wild phospholipase D Lip-Gri from Streptomyces griseofuscus is transformed through site-directed mutagenesis, and the enzyme activity of the obtained mutant is remarkably improved and is 11 times that of the wild phospholipase D Lip-Gri.
Owner:YELLOW SEA FISHERIES RES INST CHINESE ACAD OF FISHERIES SCI

Anti-inflammatory red blood cell extracellular vesicles (rbcevs)

The present disclosure describes anti-inflammatory properties of red blood cell extracellular vesicles, e.g., as mediated by heme, hemoglobin and / or phosphatidylserine content. The present disclosure describes technologies useful for the treatment of inflammatory diseases, disorders, or conditions (e.g., atherosclerosis).
Owner:NATIONAL UNIVERSITY OF SINGAPORE

Magnesium-l-threonate and neurotransmitter compositions and related methods

The present composition comprises magnesium-L-threonate and a neurotransmitter such as, but not limited to phosphatidylserine and optionally, at least one of vitamin C, vitamin B6, and vitamin D3. The composition has been shown to increase at least one of memory or cognition in clinical study subjects. The present disclosure is further directed to methods of identifying and a subject with a memory or cognitive deficiency and administering a therapeutically effective amount of a formula comprising magnesium-L-threonate and a neurotransmitter to improve the memory and / or cognitive deficiency. In some implementations, the magnesium-L-threonate is Magtein®. It is also intended that any other neurotransmitter that results in a synergistic composition of the magnesium-L-threonate and the neurotransmitter by administered to improve a subject's memory and / or cognition.
Owner:NEURO SUPPLEMENTS LLC

A method for preparing a compound spray that improves hemostasis at the wound site

This invention discloses a method for preparing a composite spray that improves hemostasis at wound sites. The composite spray includes solution A and solution B, where solution B is an aqueous solution of sodium alginate. The preparation method of solution A includes: 1. Dissolving a lipopeptide conjugate, cholesterol, distearylphosphatidylcholine, distearylphosphatidylserine, and dimethyl sulfoxide in a chloroform-methanol mixed solution to obtain a mixed system; 2. Preparing a precursor solution from the mixed system using a thin-film hydration method; 3. Adding calcium chloride to the precursor solution and reacting it in the dark to obtain solution A. This invention designs the precursor solution based on the function of natural platelets, and its function is equivalent to that of nanoplatelets. Combined with sodium alginate, it can specifically alleviate the adverse effects on the coagulation system caused by blood loss, such as fibrin degradation and reduced platelet activation, at wound sites. It has the characteristics of rapid hemostasis, good bioactivity, and rapid wound healing.
Owner:NORTHWEST UNIV

A β-carotene-grape seed extract eye-care preparation for protecting the retina

PCT designated stageWO2026115529A2Organic active ingredientsFood scienceBiotechnologyBlueberry extract
The present invention discloses a β-carotene-grape seed extract eye-care preparation for retinal protection, relating to functional health foods. The preparation comprises active components and food-acceptable excipients. In parts by weight, the active components include 1–4 parts lutein, 0.5 –2 parts meso-zeaxanthin, 2 – 6 parts β-carotene, 8 – 25 parts blueberry extract, 5 – 18 parts grape seed extract, 0.2–1 part L-ergothioneine, 0.5–3 parts saffron extract, and 1–5 parts phosphatidylserine. The excipients comprise a filler, disintegrant, binder, and lubricant, with a weight ratio of active components to excipients of 1:1 to 1:4. By combining these eight components at specific ratios, the invention achieves synergistic effects, protects retinal health, and reduces blue-light damage. Dual-phase microencapsulation based on solubility, together with standardized preparation steps, improves stability and utilization efficiency.
Owner:ZIRAOUI NOUR-EDDINE

Tolerogenic composition

Tolerogenic liposome-based compositions and uses thereof for treating immune disorders. The compositions include two populations of liposomes. The first population of liposomes has a size in the range from 2 to 200 nm, and the second population of liposomes has a size in the range from 500 to 2000 nm. The liposomes of the first and second populations carry one or more antigens. The liposomal membrane of each liposome in the first and second liposome populations include phosphatidylserine in an amount ranging from 20 to 60% by weight with respect to the total composition of the liposome's membrane.
Owner:AHEAD THERAPEUTICS SL +3